I disagree. I bet by September we will have a vaccine. It will be super fast tracked. Hell, they can even just post online the how to do it, if they don't care about the money. Then other countries immediately can make their own.
The point is though, that we can see the end of the tunnel, because so far the government hasn't told us any kind of longer term plan.
These things cannot really be fast tracked too fast.
Even if they speed things up there are various phases that are necessary. They need to first insure it works. If it works, then they need to give it to people of varying genetic make up (different races, conditions, genders, etc). If it still works, it needs to be blinded and tested again. Moreover, they need to confirm the side effects are not bad and that it doesnt make things worse.
I had read an article a while back from an epidemiologist that said even fast tracked each phase will likely take 3-4 months. The data has to roll back in and then be analyzed which is sometimes the slowest part.
The world is high on hopium when they read these things not recognizing that a "fast track" is still almost a year out at best.
Here's an article:
https://www.cnbc.com/2020/01/31/coronavirus-why-it-takes-at-least-a-year-to-make-a-vaccine.html
Here's a related paper:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1083939/
Another piece of good news is that the FDA is likely to approve the ‘Animal Rule’ in the next few weeks to months, said Sandra Qweder, Acting Director of the Office of Review Management at the FDA’s Center for Drug Evaluation and Review (CDER). ‘This rule, proposed in 1999, would allow drugs and vaccines to be reviewed and approved without human data because testing them by challenging patients with diseases such as inhalation anthrax, bubonic plague, and smallpox “is not feasible and cannot be ethically conducted”,’ Qweder said.
For most other drugs that do not fall under this rule, the agency was able to reduce the average time required for drug review from 30 to 15 months after the Prescription Drug User Fee Act (PDUFA) was passed in the USA in 1992. The FDA added nearly 700 employees to CDER and CBER (biologics) and in so doing, increased its capability of reviewing more drugs in less time. ‘Fast-Track designation, initiated by the FDA Modernization Act (FDMA) of 1997 […] is designed to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs,’ according to the CDER. ‘Actually, Fast-Track designation means that companies can apply at any stage of development to expedite their drugs,’ Qweder explained. Between 1998 and March 31, 2001 the FDA approved 10 fast-track designated products with a median response time of 55 days, according to CDER. Of these, eight are for HIV-AIDS and two for cancer.
One example of this may be the anti-diabetic compound Rezulin, which was approved after a 6-month fast-track review. The drug was withdrawn following the FDA attribution of 63 liver-failure deaths to it. Yet the drug remained on the US market for more than 2 years after the UK had withdrawn it for the same reason.
There are significant risks to fast tracking drugs. Moreover, these "fast tracked" vaccines will only be given to the most vulnerable populations where the risk of potentially fatal side effects does not outweigh the certain fatality from the virus. It won't be general issue for YEARS. It's not worth it to get excited over these prospects if you are remotely healthy. You won't be chosen for the vaccine trials and you won't be rushed into a clinic to get it. Nor would you want to be...in my opinion.